Ignite Creation Date:
2024-10-26 @ 3:43 PM
Last Modification Date:
2024-10-26 @ 3:43 PM
Study NCT ID:
NCT06654089
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-10-21
Brief Title:
A Study Evaluating Quality of Life Parameters Following Use of Emergen-C
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Real-World Evidence Study Evaluating Quality of Life Parameters Following Use of Emergen-C
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine how Emergen-C use can improve quality of life QoL in a real-world setting to help consumers and healthcare professionals understand the benefits of taking Emergen-C on a routine or daily basis
Detailed Description:
This will be a randomized double-blinded placebo-controlled clinical trial to evaluate the over-time effects of 12-weeks Emergen-C supplementation on QoL parameters in a real-world setting This study will be entirely decentralized and participants will not be required to physically attend any on-site visits All study data will be collected remotely through a study platform using the participants personal mobile device tablet or computer Sufficient participants will be screened to enroll approximately 300 eligible participants approximately 150 participants per group and approximately 240 participants are expected to complete the study approximately 120 participants per group
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None